Department of Physics, Faculty of Science, Kasetsart University, Bangkok 10900, Thailand.
Center of Calcium and Bone Research (COCAB), Faculty of Science, Mahidol University, Thailand; Department of Physiology, Faculty of Science, Mahidol University, Thailand.
Mater Sci Eng C Mater Biol Appl. 2014 May 1;38:63-72. doi: 10.1016/j.msec.2014.01.040. Epub 2014 Jan 29.
In the present study, composite scaffolds made with different weight ratios (0.5:1, 1:1 and 2:1) of bioactive glass (15Ca:80Si:5P) (BG)/polyvinyl alcohol (PVA) (PVABG) and chitosan (Chi)/collagen (Col) (ChiCol) were prepared by three mechanical freeze-thaw followed by freeze-drying to obtain the porous scaffolds. The mechanical properties and the in vitro biocompatibility of the composite scaffolds to simulated body fluid (SBF) and to rat osteoblast-like UMR-106 cells were investigated. The results from the studies indicated that the porosity and compressive strength were controlled by the weight ratio of PVABG:ChiCol. The highest compressive modulus of the composites made was 214.64 MPa which was for the 1:1 weight ratio PVABG:ChiCol. Mineralization study in SBF showed the formation of apatite crystals on the PVABG:ChiCol surface after 7 days of incubation. In vitro cell availability and proliferation tests confirmed the osteoblast attachment and growth on the PVABG:ChiCol surface. MTT and ALP tests on the 1:1 weight ratio PVABG:ChiCol composite indicated that the UMR-106 cells were viable. Alkaline phosphatase activity was found to increase with increasing culturing time. In addition, we showed the potential of PVABG:ChiCol drug delivery through PBS solution studies. 81.14% of BSA loading had been achieved and controlled release for over four weeks was observed. Our results indicated that the PVABG:ChiCol composites, especially the 1:1 weight ratio composite exhibited significantly improved mechanical, mineral deposition, biological properties and controlled release. This made them potential candidates for bone tissue engineering applications.
在本研究中,通过三次机械冷冻-解冻随后冷冻干燥制备了不同质量比(0.5:1、1:1 和 2:1)的生物活性玻璃(15Ca:80Si:5P)(BG)/聚乙烯醇(PVA)(PVABG)和壳聚糖(Chi)/胶原蛋白(Col)(ChiCol)复合支架,以获得多孔支架。研究了复合支架在模拟体液(SBF)和大鼠成骨样 UMR-106 细胞中的机械性能和体外生物相容性。研究结果表明,PVABG:ChiCol 的质量比控制了多孔支架的孔隙率和压缩强度。复合材料的最大压缩模量为 214.64 MPa,这是 1:1 质量比 PVABG:ChiCol 的压缩模量。SBF 中的矿化研究表明,在孵育 7 天后,在 PVABG:ChiCol 表面形成了磷灰石晶体。体外细胞可用性和增殖试验证实了成骨细胞在 PVABG:ChiCol 表面的附着和生长。MTT 和 ALP 试验表明,1:1 质量比的 PVABG:ChiCol 复合材料上的 UMR-106 细胞具有活力。碱性磷酸酶活性随着培养时间的增加而增加。此外,我们通过 PBS 溶液研究显示了 PVABG:ChiCol 药物输送的潜力。已经实现了 81.14%的 BSA 负载,并且观察到超过四周的控制释放。我们的结果表明,PVABG:ChiCol 复合材料,特别是 1:1 质量比的复合材料表现出显著改善的机械性能、矿物质沉积、生物性能和控制释放。这使得它们成为骨组织工程应用的潜在候选材料。